Target intelligence / Profile preview

Leishmanolysin-like pseudogene

Molecular classification
Pseudogene, Homology to metallopeptidase M8 family (leishmanolysin-like)
01

Overview

The leishmanolysin-like pseudogene (ENSG00000224245, LOC100421692) is a human genome locus predicted to have sequence similarity to leishmanolysin proteins of the metallopeptidase M8 family, but it does not encode a functional protein due to disabling mutations and is classified as a pseudogene[4][5][6]. Human pseudogenes, including this locus, typically result from ancestral duplication or retrotransposition events, followed by degradation via frameshifts or premature stop codons that abolish protein-coding capacity[1][2][6]. Pseudogenes such as this may retain some sequence similarity to coding genes but are generally considered nonfunctional, not acting as receptors, enzymes, or drug targets. There is no evidence for involvement in any regulatory role, disease association, or pharmacological activity, nor is it a biomarker for clinical use[4][5][6].

Other names
LOC100421692LMLN pseudogeneLeishmanolysin-like (Metallopeptidase M8 Family) pseudogene

Beyond the preview

Go deeper on Leishmanolysin-like pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leishmanolysin-like pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call